-
1Academic Journal
Συγγραφείς: Mukhin K.Y., Pylaeva O.A., Мarkin А.V.
Πηγή: Russian Journal of Child Neurology; Vol 19, No 1 (2024); 25‑40 ; Русский журнал детской неврологии; Vol 19, No 1 (2024); 25‑40 ; 2412-9178 ; 2073-8803
Θεματικοί όροι: sulthiame, age-dependent epilepsy with central temporal spikes (rolandic epilepsy), epileptic encephalopathy, spike-and-wave activity during sleep, focal epilepsy, efficacy, tolerability, сультиам, возрастзависимая эпилепсия с центрально-темпоральными спайками (роландическая эпилепсия), эпилептическая энцефалопатия, феномен спайк-волновой активации во сне, фокальные эпилепсии, эффективность, переносимость
Περιγραφή αρχείου: application/pdf
Relation: https://rjdn.abvpress.ru/jour/article/view/458/313; https://rjdn.abvpress.ru/jour/article/view/458
-
2Academic Journal
Συγγραφείς: K. Yu. Mukhin, O. A. Pylaeva, А. V. Мarkin, К. Ю. Мухин, О. А. Пылаева, А. В. Маркин
Πηγή: Russian Journal of Child Neurology; Том 19, № 1 (2024); 25‑40 ; Русский журнал детской неврологии; Том 19, № 1 (2024); 25‑40 ; 2412-9178 ; 2073-8803
Θεματικοί όροι: переносимость, age-dependent epilepsy with central temporal spikes (rolandic epilepsy), epileptic encephalopathy, spike-and-wave activity during sleep, focal epilepsy, efficacy, tolerability, возрастзависимая эпилепсия с центрально-темпоральными спайками (роландическая эпилепсия), эпилептическая энцефалопатия, феномен спайк-волновой активации во сне, фокальные эпилепсии, эффективность
Περιγραφή αρχείου: application/pdf
Relation: https://rjdn.abvpress.ru/jour/article/view/458/313; Мухин К.Ю., Петрухин А.С. Эпилептические синдромы. Клинико-электроэнцефалографическая диагностика и терапия. В кн.: Эпилептические синдромы. Диагностика и терапия (руководство для врачей). М.: Русский печатный двор, 2023. С. 146–323.; Мухин К.Ю., Пылаева О.А. Новая классификация эпилептических синдромов Международной противоэпилептической лиги (2022 г.): основные дефиниции и принципы; отличия от проекта классификации; комментарии и обсуждение. Вестник эпилептологии 2022:4–14.; Мухин К.Ю., Петрухин А.С., Миронов М.Б. и др. Эпилепсия с электрическим эпилептическим статусом медленного сна: диагностические критерии, дифференциальный диагноз и подходы к терапии. М., 2005. 32 с.; Мухин К.Ю. Идиопатическая фокальная эпилепсия с псевдогенерализованными приступами – особая форма эпилепсии в детском возрасте. Русский журнал детской неврологии 2009;4(2):3–19.; Мухин К.Ю., Пылаева О.А., Какаулина В.С., Бобылова М.Ю. Проект международной классификации эпилептических синдромов 2021 г. с обсуждением. М.: Русский печатный двор, 2022. 160 с.; Пылаева О.А., Мухин К.Ю. Побочные эффекты антиэпилептической терапии: общие закономерности развития и принципы профилактики. В кн.: Эпилептические синдромы. Диагностика и терапия. Руководство для врачей. 5-е изд-е. М.: Русский печатный двор, 2023. С. 540–596.; Пылаева О.А., Мухин К.Ю., Петрухин А.С. Побочные эффекты антиэпилептической терапии. М.: Гранат, 2016. 232 c.; Эпилепсия. Атлас электроклинической диагностики и терапии. Tом 1. М.: Русский печатный двор, 2023. 912 с.; Al Kaisi A.H., McGuire R.J. The effect of sulthiame on disturbed behaviour in mentally subnormal patients. Brit J Psychiatry 1974;124:45–9. DOI:10.1192/bjp.124.1.45; Bast T., Völp A., Wolf C. et al. The influence of sulthiame on EEG in children with benign childhood epilepsy with centrotemporal spikes (BECTS). Epilepsia 2003;44:215–20.; Ben-Zeev B., Watemberg N., Lerman P. et al. Sulthiame in childhood epilepsy. Pediatr Int 2004;46(5):521–4.; Bonnet U. Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons. Epilepsia 2002;43:469–74.; Borusiak P., Langer Th., Heruth M. et al. Antiepileptic drugs and bone metabolism in children: Data from 128 patients. J Child Neurol 2013;28(2):176–83.; Bradicich M., Siciliano M., Schiavi E. et al. ERS International; Campos M.S., Ayres L.R., Morelo M.R. et al. Efficacy and tolerability of antiepileptic drugs in patients with focal epilepsy: Systematic review and network meta-analyses. Pharmacotherapy 2016;36(12):1255–71. DOI:10.1002/phar.1855; Caraballo R., Reyes G., Semprino M. et al. Use of sulthiame as add-on therapy in children with non-self-limited focal epilepsies of childhood. Epilepsy Behav 2023;143:109220. DOI:10.1016/j.yebeh.2023.109220; Caraballo R.H., Flesler S., Reyes Valenzuela G. et al. Sulthiame add-on therapy in children with Lennox–Gastaut syndrome: A study of 44 patients. Seizure 2018;62:55–8. DOI:10.1016/j.seizure.2018.09.019; Caraballo R.H., Reyes Valenzuela G., Fortini S. et al. Use of sulthiame as add-on therapy in children with myoclonic atonic epilepsy: A study of 35 patients. Epilepsy Behav 2022;131(Pt A): 108702. DOI:10.1016/j.yebeh.2022.108702; Cheng W., Yang Y., Chen Y. et al. Anti-seizure medication treatment of benign childhood epilepsy with centrotemporal spikes: A systematic review and meta-analysis. Front Pharmacol 2022;13:821639. DOI:10.3389/fphar.2022.821639; Dao K., Thoueille P., Decosterd L.A. et al. Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteers. Pharmacol Res Perspect 2020;8(1):e00558. DOI:10.1002/prp2.558; Davico C., Canavese C., Vittorini R. et al. Anticonvulsants for psychiatric disorders in children and adolescents: A systematic review of their efficacy. Front Psychiatry 2018;9:270.; Doose H., Baier W.K., Ernst J.-P. et al. Benign partial epilepsy – treatment with sulthiame. Develop Med Child Neurol 1988;30:683, 684. DOI:10.1111/j.1469-8749.1988.tb04809.x; Fejerman N., Caraballo R. Benign focal epilepsies in infancy, childhood and adolescence. UK: JL Eurotext, 2007. 266 p.; Fong Сh.Y., Hashim N., Gan Ch.S. et al. Sulthiame-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Eur J Paediatr Neurol 2016;20(6):957–61.; Gerstl L., Willimsky E., Remi C. et al. A systematic review of seizure-freedom rates in patients with benign epilepsy of childhood with centrotemporal spikes receiving antiepileptic drugs. Clin Neuropharmacol 2021;44(2):39–46. DOI:10.1097/WNF.0000000000000435; Gobbi G., Grosso S. Atypical benign partial epilepsy of childhood. In: Atlas of Epilepsies. London: Springer, 2010. Pp. 923–930.; Gorman K.M., Shahwan A. Sultiame revisited: Treatment of refractory absence seizures. Epileptic Disord 2016;18(3):329–33. DOI:10.1684/epd.2016.0850; Guerrini R., Marini C. Epileptic encephalopathies. In: Epilepsy and Epileptic Seizures. Oxford: Oxford University Press, 2013. Pp. 177–185.; Guerrini R., Mari F., Auvin S., Dravet Ch. Myoclonic epilepsies in infancy and early childhood. In: Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th edn. Paris: John Libbey Eurotext Ltd., 2019. Pp. 173–188.; Hadi D.A., Mohamed A.R., Rethanavelu K., Khoo T.B. Clonic seizures, continuous spikes-and-waves during slow sleep, choreoathetosis and response to sulthiame in a child with FRRS1L encephalopathy. Brain Dev 2022;44(1):44–9. DOI:10.1016/j.braindev.2021.08.006; Hedner J., Stenlof K., Zou D. et al. A randomized controlled clinical trial exploring safety and tolerability of sulthiame in sleep apnea. Am J Respir Crit Care Med 2022;205(12):1461–9. DOI:10.1164/rccm.202109-2043OC; Heger K., Skipsfjord J., Kiselev Y. et al. Changes in the use of antiseizure medications in children and adolescents in Norway, 2009–2018. Epilepsy Res 2022;181:106872. DOI:10.1016/j.eplepsyres.2022.106872; Hoff E., Strassberger C., Zou D. et al. Modification of endotypic traits in OSA by the carbonic anhydrase inhibitor sulthiame. Chest 2023:S0012-3692(23)05544-7.; Josephson C.B., Gonzalez-Izquierdo A., Denaxas S. et al. Independent associations of incident epilepsy and enzyme-inducing and non-enzyme-inducing antiseizure medications with the development of osteoporosis. JAMA Neurol 2023;80(8):843–50. DOI:10.1001/jamaneurol.2023.1580; Kanmaz S., Simsek E., Serin H.M. et al. Sulthiame add-on treatment in children with epileptic encephalopathy with status epilepticus: an efficacy analysis in etiologic subgroups. Neurol Sci 2021;42(1):183–91. DOI:10.1007/s10072-020-04526-y; Kramer U., Sagi L., Goldberg-Stern H. et al. Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia 2009;50(6):1517–24.; Leniger T., Wiemann M., Bingmann D. et al. Comorbidity between epilepsy and sleep disorders. Epilepsy Res 2020;90(3):171–7.; Milburn-McNulty P., Panebianco M., Marson A.G. Sulthiame monotherapy for epilepsy. Cochrane Database Syst Rev 2021;9(9): CD010062. DOI:10.1002/14651858.CD010062.pub3; Miranda M.J., Ahmad B.B. Treatment of rolandic epilepsy. Ugeskr Laeger 2017;179(48):V06170482.; Moffatt W.R., Siddiqui A.R., MacKay D.N. The use of sulthiame with disturbed mentally subnormal patients. Brit J Psychiatry 1970;117(541):673–8. DOI:10.1192/bjp.117.541.673; Nobili L., de Weerd A., Rubboli G. et al. Standard procedures for the diagnostic pathway of sleep-related epilepsies and comorbid sleep disorders: An EAN, ESRS and ILAE-Europe consensus review. Eur J Neurol 2021;28(1):15–32. DOI:10.1111/ene.14468; Oguni H., Tanaka T., Hayashi K. et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002;33:122–32.; Oguni H., Hayashi K., Imai K. et al. Idiopathic myoclonic-astatic epilepsy of early childhood – nosology based on electrophysiologic and long-term follow up study of patients. Adv Neurol 2005;95:157–74.; Quade A., Thiel A., Kurth I. et al. Paroxysmal tonic upgaze: A heterogeneous clinical condition responsive to carbonic anhydrase inhibition. Eur J Paediatr Neurol 2020;25:181–6. DOI:10.1016/j.ejpn.2019.11.002; Panayiotopoulos C.P. A Clinical Guide to Epileptic Syndromes and Their Treatment. 2nd edn. Springer, 2010. Pp. 45–49; 325–335.; Panayiotopoulos С.P. Principles of therapy in the epilepsies. In: Clinical Guide to Epileptic Syndromes and Their Treatment. Springer, 2007. Pp. 155–184.; Patsalos P.N., St Louis E.K. Sulthiame. In: The Epilepsy Prescriber’s Guide to Antiepileptic Drugs. Cambridge: Cambridge University Press, 2018. Pp. 282–291.; Pereira-Nunes J., Sousa J.M., Fonseca J. et al. Successful treatment of a child with epileptic encephalopathy with spike-wave activation in sleep and GRIN2A variant using sulthiame. Cureus 2023;15(2):e34686. DOI:10.7759/cureus.34686; Rahman S., Bibi S., Javed T. et al. Review: Therapeutic potential of carbonic anhydrase inhibitors. Pak J Pharm Sci 2019;32(2):709–20.; Ramantani G., Bolsterli B.K., Alber M. et al. Treatment of infantile spasm syndrome: update from the interdisciplinary guideline committee coordinated by the German-Speaking Society of Neuropediatrics. Neuropediatrics 2022;53(6):389–401. DOI:10.1055/a-1909-2977; Rating D., Wolf C., Bast T. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: A 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group. Epilepsia 2000;41:1284–8.; Reimers A., Berg J.A., Burns M.L. et al. Reference ranges for antiepileptic drugs revisited: A practical approach to establish national guidelines. Drug Des Devel Ther 2018;12:271–80. DOI:10.2147/DDDT.S154388; Riviello J.J. The Landau–Kleffner syndrome and epilepsy with continuous spike-waves during sleep. In: Pediatric Epilepsy. 4th edn. New York: Demos, 2017. Pp. 393–406.; Sivathamboo S., Myers K.A., Pattichis A. et al. Sleep and respiratory abnormalities in adults with developmental and epileptic encephalopathies using polysomnography and video-EEG monitoring. Epilepsia Open 2023;8(3):1157–68. DOI:10.1002/epi4.12772.; Specchio N., Wirrell E.C., Scheffer I.E. et al. ILAE classification and definition of epilepsy syndromes with onset in childhood: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia 2022;63(6):1398–442.; Steinhoff B., Bast T. Compendium Antiepileptic Drugs. Berlin: Deutsche Gesellschaft für Epileptologie, 2017–2018.; Steinhoff B., Bast T. Compendium Antiepileptic Drugs. Berlin: Deutsche Gesellschaft für Epileptologie, 2019–2020.; Stephani U. Typical semiology of benign childhood epilepsy with centrotemporal spikes (BCECTS). Epileptic Disord 2000;2(Suppl 1):3, 4.; Stephani U., Carlsson G. The spectrum from BCECTS to LKS: The rolandic EEG trait-impact on cognition. Epilepsia 2006;47(Suppl 2):67–70. DOI:10.1111/j.1528-1167.2006.00694.x; Swiderska N., Hawcutt D., Eaton V. et al. Sulthiame in refractory paediatric epilepsies: An experience of an “old” antiepileptic drug in a tertiary paediatric neurology unit. Seizure 2011;20:805–8. DOI:10.1016/j.seizure.2011.08.006; Tacke M., Borggraefe I., Gerstl L. et al. Effects of levetiracetam and sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial. Seizure 2018;56:115–20. DOI:10.1016/j.seizure.2018.01.015; Tan H.J., Singh J., Gupta R., de Goede C. Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centrotemporal spikes. Cochrane Database Syst Rev 2014;2014(9):CD006779. DOI:10.1002/14651858.CD006779.pub2; Tassinari C.A., Cantaluppo G., Dalla Bernardina B. et al. Encephalopathy related to status epilepticus during slow sleep (ESES) including Landau–Kleffner syndrome. In: Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Paris: John Libbey Eurotext, 2012. Pp. 255–275.; Tassinari C.A., Cantaluppo G., Dalla Bernardina B. et al. Encephalopathy related to status epilepticus during slow sleep (ESES) including Landau–Kleffner syndrome. In: Epileptic Syndromes in Infancy, Childhood and Adolescence. 6th edn. Paris: John Libbey Eurotext, 2019. Pp. 261–283.; Topcu Y., Kılıc B., Tekin H.G. et al. Effects of sulthiame on seizure frequency and EEG in children with electrical status epilepticus during slow sleep. Epilepsy Behav 2021;116:107793. DOI:10.1016/j.yebeh.2021.107793; Uliel-Sibony S., Chernuha V., Tokatly Latzer I., Leitner Y. Epilepsy and attention-deficit/hyperactivity disorder in children and adolescents: An overview of etiology, prevalence, and treatment. Front Hum Neurosci 2023;17:1021605.; Verrotti A., Moavero R., Panzarino G. et al. The challenge of pharmacotherapy in children and adolescents with epilepsy-ADHD comorbidity. Clin Drug Investig 2018;38:1–8.; Wirrell E.С., Nabbout R., Scheffer I. et al. Methodology for classification and definition of epilepsy syndromes: Report of the ILAE Task Force on nosology and definitions. Epilepsia 2022;63(6):1333–48.; https://rjdn.abvpress.ru/jour/article/view/458